Hôpital Pitié Salpêtrière - AP-HP

98 currently recruiting clinical trials
Create patient profile for matching
Phase 2 Acute leukemia #NCT05260528 #2022-500295-60-00
Required histologic types
Acute myeloid leukemia (AML)
Required number of previous lines of therapy
None
Hôpital Pitié Salpêtrière - AP-HP (Paris)
Centre Hospitalier Universitaire de Nice
Phase 2 Lymphoma #NCT06547866
Required histologic types
B cell lymphoma
Required histologic sub types
Waldenström lymphoma
Required central nervous system lesions
None Treated / Controled
Required renal function statuses
> 60 ml/min 50-60 ml/min
Required number of previous lines of therapy
1 2 3 or more
Excluded previous treatments
Systemic Treatment-Naive
Hôpital Pitié Salpêtrière - AP-HP (Paris)
French Innovative Leukemia Organisation (FILO)
Phase 2 Liver and bile duct cancer #NCT07036380 #2024-520029-35-00
Required histologic sub types
Intrahepatic cholangiocarcinoma Extrahepatic cholangiocarcinoma
Required disease stage
Locally Advanced Metastatic
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Excluded previous treatments at advanced or metastatic stage
Immunotherapy
Hôpital Pitié Salpêtrière - AP-HP (Paris)
Centre Hospitalier Universitaire de Besancon
Phase 2 Acute leukemia #NCT05917405
Required histologic types
Acute myeloid leukemia (AML)
Required renal function statuses
> 60 ml/min 50-60 ml/min
Required number of previous lines of therapy
None 1
Required previous treatments
Systemic Treatment-Naive Chemotherapy
Hôpital Pitié Salpêtrière - AP-HP (Paris)
Hôpital universitaire de Nantes
Phase 2 Liver and bile duct cancer #NCT06218420
Required histologic sub types
Hepatocellular carcinoma
Required disease stage
Localized
Required liver status
Unhealthy
Required Child-Pugh scores
A B
Required number of previous lines of therapy for current stage of disease
None
Hôpital Pitié Salpêtrière - AP-HP (Paris)
Assistance Publique - Hôpitaux de Paris
Phase 2 CLL & Richter's syndrome #NCT06186648 #2022-501554-11-00
Required histologic types
Richter's syndrome
Required central nervous system lesions
None Treated / Controled
Required renal function statuses
> 60 ml/min
Required number of previous lines of therapy
None
Required previous treatments
Systemic Treatment-Naive
Excluded previous treatments
Bispecific T-cell engager antibodies Allogeneic stem cell transplant
Hôpital Pitié Salpêtrière - AP-HP (Paris)
French Innovative Leukemia Organisation (FILO)
Phase 2 Lymphoma #NCT06931652 #2023-505834-84-00
Required histologic types
B cell lymphoma
Required histologic sub types
Primary cerebral lymphoma
Required central nervous system lesions
Actives
Required renal function statuses
> 60 ml/min 50-60 ml/min 30-50 ml/min
Required number of previous lines of therapy
1 2 3 or more
Required previous treatments
Chemotherapy
Excluded previous treatments
Systemic Treatment-Naive Bispecific T-cell engager antibodies Allogeneic stem cell transplant
Hôpital Pitié Salpêtrière - AP-HP (Paris)
The Lymphoma Academic Research Organisation (LYSARC)
Phase 2 Bladder / Urinary Tract / Urethral cancer #NCT03547973 #2023-508302-24-00
Required histologic types
Invasive bladder cancer
Required histologic sub types
Urothelial carcinoma
Required disease stage
Locally Advanced Metastatic
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Hôpital Pitié Salpêtrière - AP-HP (Paris)
Gilead Sciences
Phase 2 Pancreas cancer #NCT04570943
Required histologic sub types
Adenocarcinoma
Required disease stage
Locally Advanced
Required number of previous lines of therapy for current stage of disease
None
Required previous treatments at localized stage
Systemic Treatment-Naive
Required previous treatments at advanced or metastatic stage
Systemic Treatment-Naive
Hôpital Pitié Salpêtrière - AP-HP (Paris)
Institut du Cancer de Montpellier - Val d'Aurelle
Phase 2 Lymphoma #NCT06534437 #2024-513098-31-00
Required histologic types
B cell lymphoma
Required histologic sub types
Large B cell lymphoma Indolent transformed lymphoma
Required central nervous system lesions
None
Required number of previous lines of therapy
2 3 or more
Required previous treatments
Chemotherapy Bispecific T-cell engager antibodies Monoclonal antibodies
Excluded previous treatments
Systemic Treatment-Naive
Hôpital Pitié Salpêtrière - AP-HP (Paris)
Ryvu Therapeutics SA